277 related articles for article (PubMed ID: 29534334)
1. Synthesis, Biological Evaluation and Molecular Modeling Studies of Propargyl-Containing 2,4,6-Trisubstituted Pyrimidine Derivatives as Potential Anti-Parkinson Agents.
Kumar B; Kumar M; Dwivedi AR; Kumar V
ChemMedChem; 2018 Apr; 13(7):705-712. PubMed ID: 29534334
[TBL] [Abstract][Full Text] [Related]
2. Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase.
Kumar B; Kumar V; Prashar V; Saini S; Dwivedi AR; Bajaj B; Mehta D; Parkash J; Kumar V
Eur J Med Chem; 2019 Sep; 177():221-234. PubMed ID: 31151057
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, monoamine oxidase inhibitory activity and computational study of novel isoxazole derivatives as potential antiparkinson agents.
Agrawal N; Mishra P
Comput Biol Chem; 2019 Apr; 79():63-72. PubMed ID: 30731360
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation and molecular modeling studies of phenyl-/benzhydrylpiperazine derivatives as potential MAO inhibitors.
Kumar B; Sheetal ; Mantha AK; Kumar V
Bioorg Chem; 2018 Apr; 77():252-262. PubMed ID: 29421700
[TBL] [Abstract][Full Text] [Related]
5. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel 2,3-dihydro-1H-inden-1-amine derivatives as selective monoamine oxidase B inhibitors.
Li S; Lv X; Cheng K; Tian Y; Huang X; Kong H; Duan Y; Han J; Liao C; Xie Z
Bioorg Med Chem Lett; 2019 May; 29(9):1090-1093. PubMed ID: 30833108
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase inhibitory activities of heterocyclic chalcones.
Minders C; Petzer JP; Petzer A; Lourens AC
Bioorg Med Chem Lett; 2015 Nov; 25(22):5270-6. PubMed ID: 26432037
[TBL] [Abstract][Full Text] [Related]
8. Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson's Disease.
Nam MH; Park M; Park H; Kim Y; Yoon S; Sawant VS; Choi JW; Park JH; Park KD; Min SJ; Lee CJ; Choo H
ACS Chem Neurosci; 2017 Jul; 8(7):1519-1529. PubMed ID: 28332824
[TBL] [Abstract][Full Text] [Related]
9. The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase.
Engelbrecht I; Petzer JP; Petzer A
Bioorg Med Chem Lett; 2015 May; 25(9):1896-900. PubMed ID: 25857942
[TBL] [Abstract][Full Text] [Related]
10. Indanones as high-potency reversible inhibitors of monoamine oxidase.
Mostert S; Petzer A; Petzer JP
ChemMedChem; 2015 May; 10(5):862-73. PubMed ID: 25820651
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of monoamine oxidase by indole and benzofuran derivatives.
Prins LH; Petzer JP; Malan SF
Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099
[TBL] [Abstract][Full Text] [Related]
12. MAO enzymes inhibitory activity of new benzimidazole derivatives including hydrazone and propargyl side chains.
Can ÖD; Osmaniye D; Demir Özkay Ü; Sağlık BN; Levent S; Ilgın S; Baysal M; Özkay Y; Kaplancıklı ZA
Eur J Med Chem; 2017 May; 131():92-106. PubMed ID: 28301816
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 2-substituted 4(3H)-quinazolinone thioether derivatives as monoamine oxidase inhibitors.
Qhobosheane MA; Petzer A; Petzer JP; Legoabe LJ
Bioorg Med Chem; 2018 Nov; 26(20):5531-5537. PubMed ID: 30279044
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of biaryl derivatives for structural characterization of selective monoamine oxidase B inhibitors toward Parkinson's disease therapy.
Yeon SK; Choi JW; Park JH; Lee YR; Kim HJ; Shin SJ; Jang BK; Kim S; Bahn YS; Han G; Lee YS; Pae AN; Park KD
Bioorg Med Chem; 2018 Jan; 26(1):232-244. PubMed ID: 29198609
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and monoamine oxidase inhibitory activity of new pyridazine-, pyrimidine- and 1,2,4-triazine-containing tricyclic derivatives.
Carotti A; Catto M; Leonetti F; Campagna F; Soto-Otero R; Méndez-Alvarez E; Thull U; Testa B; Altomare C
J Med Chem; 2007 Nov; 50(22):5364-71. PubMed ID: 17910428
[TBL] [Abstract][Full Text] [Related]
16. 2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.
Legoabe LJ; Petzer A; Petzer JP
Drug Des Devel Ther; 2015; 9():3635-44. PubMed ID: 26203229
[TBL] [Abstract][Full Text] [Related]
17. Pyrimido[1,2-b]indazole derivatives: Selective inhibitors of human monoamine oxidase B with neuroprotective activity.
Jismy B; El Qami A; Pišlar A; Frlan R; Kos J; Gobec S; Knez D; Abarbri M
Eur J Med Chem; 2021 Jan; 209():112911. PubMed ID: 33071056
[TBL] [Abstract][Full Text] [Related]
18. 3-Coumaranone derivatives as inhibitors of monoamine oxidase.
Van Dyk AS; Petzer JP; Petzer A; Legoabe LJ
Drug Des Devel Ther; 2015; 9():5479-89. PubMed ID: 26491258
[TBL] [Abstract][Full Text] [Related]
19. Indoles and 1-(3-(benzyloxy)benzyl)piperazines: Reversible and selective monoamine oxidase B inhibitors identified by screening an in-house compound library.
Knez D; Hrast M; Frlan R; Pišlar A; Žakelj S; Kos J; Gobec S
Bioorg Chem; 2022 Feb; 119():105581. PubMed ID: 34990933
[TBL] [Abstract][Full Text] [Related]
20. Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B.
Van der Walt MM; Terre'Blanche G; Petzer JP; Petzer A
Eur J Med Chem; 2017 Jan; 125():1193-1199. PubMed ID: 27855360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]